Philadelphia Chromosome-negative B-cell Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Philadelphia Chromosome-negative B-cell Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 trial is evaluating DA-EPOCH chemotherapy with or without rituximab, in combination with tafasitamab, for newly diagnosed Philadel…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating the effectiveness and safety of blinatumomab combined with donor lymphocyte infusion as maintenance therapy after a…
-
CLINICAL_TRIALS research · 2019-02-19Clinical Trial Update: Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults
Update on a multicenter trial evaluating treatment for Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in young adults;…